Genzyme update on supply of Thyrogen® (thyrotropin alfa for injection)
September 12, 2011
Genzyme would like to provide an update on Thyrogen availability. Intermittent shipments of the product have resumed globally with the expectation that current supply projections for the remainder of 2011 will meet approximately 40 to 60 percent of global demand for Thyrogen. Genzyme continues to advise health care providers not to schedule any new Thyrogen treatments until they have secured product.